{"id":44393,"date":"2022-05-26T19:01:58","date_gmt":"2022-05-26T17:01:58","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\/"},"modified":"2022-05-26T19:01:58","modified_gmt":"2022-05-26T17:01:58","slug":"medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\/","title":{"rendered":"Medisca Drives Worldwide Access to Thyroid through Distribution License with SUANFARMA"},"content":{"rendered":"
\n

MONTREAL–(BUSINESS WIRE)–On March 16, 2022, Medisca, a global supplier of pharmaceutical ingredients and equipment, entered into an exclusive agreement with SUANFARMA, a European-based manufacturer and distributor of pharmaceutical ingredients, for the global supply and distribution of Thyroid Powder, USP<\/b>, by leveraging its exclusive partnership with pharmaceutical manufacturer, Sichuan Deebio Pharmaceutical Co., Ltd (Deebio).\n<\/p>\n

<\/a><\/p>\n

\n\u201cPartnering with Deebio in June 2021 was a huge milestone for the pharmaceutical compounding industry as it allowed us to secure and stabilize the supply of high quality Thyroid Powder for the US market,\u201d said Panagiota Danopoulos, Senior Vice President of Global Strategy & Innovation at Medisca.\n<\/p>\n

\n\u201cAfter going to market, we immediately realized that the demand for Thyroid Powder extended outside of our usual distribution channels to compounding pharmacies,\u201d continued Danopoulos. \u201cAnd we had the capacity to upscale supply to make this critical ingredient accessible to various markets, channels, and patients across the globe. A need we will now meet through our partnership with SUANFARMA.\u201d\n<\/p>\n

\nAlready an existing partner and supplier of ingredients to Medisca, striking this agreement with SUANFARMA involved reinforcing a well-established symbiotic relationship between two companies committed to world-class quality, service, and price.\n<\/p>\n

\n\u201cThe quality standards set, transparency created, and commitment established between Medisca and Deebio, is what gave us the confidence in choosing Medisca as our primary supplier of Thyroid Powder, USP,\u201d said Gustavo Adolfo Porras, Head of Sales, North America at SUANFARMA. \u201cWe look forward to continuing to expand our strong relationship with Medisca.\u201d\n<\/p>\n

\nFor Medisca, the mission is simple \u2013 to drive forward worldwide access to qualified products<\/b> by developing strategic partnerships aligned to the same standards of quality, consistency, and affordability that define Medisca.\n<\/p>\n

\nMedisca<\/b> remains the leading supplier of Thyroid Powder, USP to compounding pharmacies. Available for purchase online here<\/a>.\n<\/p>\n

\nSUANFARMA<\/b> will now streamline distribution to Medisca\u2019s supply of Thyroid Powder, USP to other channels and markets.\n<\/p>\n

\nAbout MEDISCA\u00ae<\/b>\n<\/p>\n

\nMEDISCA is a global leader in healthcare with well-established footings in pharmaceutical compounding and advancements in scientific labs, cosmetics, other healthcare industries. For 30+ years, MEDISCA has been serving pharmacies and allied healthcare institutions with cutting-edge offerings and passionate commitment, developing a worldwide network dedicated to personalized medicine. Through genuine relationships, worry-free experiences, convenient processes, and strategic global partnerships, MEDISCA provides top-quality and innovative products, industry-leading services, and world-class support systems. For more information visit www.medisca.com<\/a> and follow us on Twitter at @medisca<\/a>.\n<\/p>\n

\nAbout SUANFARMA<\/b>\n<\/p>\n

\nSUANFARMA founded in 1993, is a B2B life science partner specialized in the development, production, and commercialization of ingredients for the pharmaceutical, veterinary and nutraceutical industries. Our facilities comply with the highest existing regulations in the pharmaceutical industry. With the support of a consolidated and strong commercial network with 12 local offices placed strategically around the world, SUANFARMA provides its services to more than 3.000 active customers in over 70 countries. For more information, visit www.suanfarma.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nPanagiota Danopoulos
\n
SVP Global Strategy & Innovation at Medisca
\n
www.medisca.com<\/a>
1-800-665-6334\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MONTREAL–(BUSINESS WIRE)–On March 16, 2022, Medisca, a global supplier of pharmaceutical ingredients and equipment, entered into an exclusive agreement with SUANFARMA, a European-based manufacturer and distributor of pharmaceutical ingredients, for the global supply and distribution of Thyroid Powder, USP, by leveraging its exclusive partnership with pharmaceutical manufacturer, Sichuan Deebio Pharmaceutical Co., Ltd (Deebio). \u201cPartnering with … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44393","6":"format-standard","7":"category-industry"},"yoast_head":"\nMedisca Drives Worldwide Access to Thyroid through Distribution License with SUANFARMA - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medisca Drives Worldwide Access to Thyroid through Distribution License with SUANFARMA - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MONTREAL–(BUSINESS WIRE)–On March 16, 2022, Medisca, a global supplier of pharmaceutical ingredients and equipment, entered into an exclusive agreement with SUANFARMA, a European-based manufacturer and distributor of pharmaceutical ingredients, for the global supply and distribution of Thyroid Powder, USP, by leveraging its exclusive partnership with pharmaceutical manufacturer, Sichuan Deebio Pharmaceutical Co., Ltd (Deebio). \u201cPartnering with ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-26T17:01:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220526005571\/en\/1468596\/21\/Medisca_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Medisca Drives Worldwide Access to Thyroid through Distribution License with SUANFARMA\",\"datePublished\":\"2022-05-26T17:01:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\\\/\"},\"wordCount\":498,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220526005571\\\/en\\\/1468596\\\/21\\\/Medisca_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\\\/\",\"name\":\"Medisca Drives Worldwide Access to Thyroid through Distribution License with SUANFARMA - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220526005571\\\/en\\\/1468596\\\/21\\\/Medisca_Logo.jpg\",\"datePublished\":\"2022-05-26T17:01:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220526005571\\\/en\\\/1468596\\\/21\\\/Medisca_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220526005571\\\/en\\\/1468596\\\/21\\\/Medisca_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medisca Drives Worldwide Access to Thyroid through Distribution License with SUANFARMA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medisca Drives Worldwide Access to Thyroid through Distribution License with SUANFARMA - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\/","og_locale":"en_US","og_type":"article","og_title":"Medisca Drives Worldwide Access to Thyroid through Distribution License with SUANFARMA - Pharma Trend","og_description":"MONTREAL–(BUSINESS WIRE)–On March 16, 2022, Medisca, a global supplier of pharmaceutical ingredients and equipment, entered into an exclusive agreement with SUANFARMA, a European-based manufacturer and distributor of pharmaceutical ingredients, for the global supply and distribution of Thyroid Powder, USP, by leveraging its exclusive partnership with pharmaceutical manufacturer, Sichuan Deebio Pharmaceutical Co., Ltd (Deebio). \u201cPartnering with ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-26T17:01:58+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220526005571\/en\/1468596\/21\/Medisca_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Medisca Drives Worldwide Access to Thyroid through Distribution License with SUANFARMA","datePublished":"2022-05-26T17:01:58+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\/"},"wordCount":498,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220526005571\/en\/1468596\/21\/Medisca_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\/","url":"https:\/\/pharma-trend.com\/en\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\/","name":"Medisca Drives Worldwide Access to Thyroid through Distribution License with SUANFARMA - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220526005571\/en\/1468596\/21\/Medisca_Logo.jpg","datePublished":"2022-05-26T17:01:58+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220526005571\/en\/1468596\/21\/Medisca_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220526005571\/en\/1468596\/21\/Medisca_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/medisca-drives-worldwide-access-to-thyroid-through-distribution-license-with-suanfarma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Medisca Drives Worldwide Access to Thyroid through Distribution License with SUANFARMA"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44393","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44393"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44393\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44393"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44393"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44393"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}